Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey

Celik S., KIZILAY F., YÖRÜKOĞLU K., Ozen H., AKDOĞAN B., İZOL V., ...More

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, vol.20, no.1, pp.19-25, 2021 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.4274/uob.galenos.2020.1677
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.19-25
  • Keywords: Prostate cancer, radical prostatectomy, clinically insignificant prostate cancer, Epstein criteria, 12-core prostate biopsy scheme, PERINEURAL INVASION, ACTIVE SURVEILLANCE, NEEDLE-BIOPSY, ADENOCARCINOMA, STAGE, CANDIDATES, OUTCOMES, UPDATE, EXTENT, MEN
  • Dokuz Eylül University Affiliated: Yes


Objective: The aim of this study is to investigate the relevance of the Epstein criteria for the 12-core transrectal prostate biopsy (TRUS-Bx) scheme with the evaluation of clinicopathologic data recorded in the Urologic Cancer Database - Prostate (UroCaD-P), Urooncology Association, Turkey (UOAT).